Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure

Reproductive BioMedicine Online

Volumn 25, Issue 3, 2012, Pages 254-260

  Lan, Vuong Thi Ngoc ^a   Khang, Vu Nhat ^b   Nhu, Giang Huynh ^b   Tuong, Ho Manh ^c  

^a UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^b IVFAS   (Viet Nam)

^c VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

Author keywords

atosiban; clinical pregnancy; implantation rate; IVF embryo transfer; uterine contractility

Indexed keywords

ATOSIBAN;

ADULT; ARTICLE; CLINICAL TRIAL; CRYOPRESERVATION; DRUG EFFICACY; EMBRYO TRANSFER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NIDATION; PREGNANCY OUTCOME; PREGNANCY RATE; UTERUS CONTRACTION;

ADOLESCENT; ADULT; COHORT STUDIES; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HORMONE ANTAGONISTS; HUMANS; INFERTILITY; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; REPRODUCTIVE TECHNIQUES, ASSISTED; TOCOLYTIC AGENTS; UTERINE CONTRACTION; VASOTOCIN;

EID: 84865746378     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.05.014     Document Type: Article

References (48)

1. J.S. Abramowicz, and D.F. Archer Uterine endometrial peristalsis-a transvaginal ultrasound study Fertil. Steril. 54 1990 451 454
2. M. Akerlund, T. Bossmar, R. Brouard, A. Kostrzewska, T. Laudanski, A. Lemancewicz, C. Serradeil-Le Gal, and M. Steinwall Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women Br. J. Obstet. Gynaecol. 106 1999 1047 1053
3. J.M. Ayoubi, M. Epiney, P.A. Brioschi, R. Fanchin, D. Chardonnens, and D. de Ziegler Comparison of changes in uterine contraction frequency after ovulation in the menstrual cycle and in vitro fertilization cycles Fertil. Steril. 79 2003 1101 1105
4. R. Bernabeu, M. Roca, A. Torres, and J. Ten Indomethacin effect on implantation rates in oocyte recipients Hum. Reprod. 21 2006 364 369
5. C. Blockeel, R. Pierson, B. Popovic-Todorovic, H. Visnova, J.A. García-Velasco, M. Mrázek, P.N. Barri, P. Pierzynski, W. Kuczynski, P. Devroey, V. Breinholt, L. Erichsen, B.M. Klein, and J.C. Arce Effects of barusiban and atosiban on frequency of uterine contractions in the luteal phase after stimulation: a randomized placebo controlled trial Hum. Reprod. 24 Suppl. 1 2009 i26
6. R. De Heus, E.J. Mulder, J.B. Derks, and G.H. Visser Acute tocolysis for uterine activity reduction in term labor: a review Obstet. Gynecol. Surv. 63 2008 383 388
7. European Atosiban Study Group The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study Acta Obstet. Gynecol. Scand. 80 2001 413 422
8. R. Fanchin, C. Righini, F. Olivennes, S. Taylor, D. de Ziegler, and R. Frydman Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization Hum. Reprod. 13 1998 1968 1974
9. R. Fanchin, J.M. Ayoubi, F. Olivennes, C. Righini, D. de Ziegler, and R. Frydman Hormonal influence on the uterine contractility during ovarian stimulation Hum. Reprod. 15 Suppl 1 2000 90 100
10. R. Fanchin, C. Righini, D. de Ziegler, F. Olivennes, N. Ledée, and R. Frydman Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer Fertil. Steril. 75 2001 1136 1140
11. French/Australian Atosiban Investigators Group Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol Eur. J. Obstet. Gynecol. Reprod. Biol. 98 2001 177 185
12. Frydman, R.; 2004. Impact of embryo transfer techniques on implantation rates. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction 33, S36-39. [Article in French].
13. L. Gianaroli, M.C. Magli, A.P. Ferraretti, A. Fiorentino, J. Garrisi, and S. Munné Preimplantation genetic diagnosis increases the implantation rate in human in vitro fertilization by avoiding the transfer of chromosomally abnormal embryos Fertil. Steril. 68 1997 1128 1131
14. T.M. Goodwin, G. Valenzuela, H. Silver, R. Hayahsi, G.W. Creasy, and R. Lane Treatment of preterm labor with the oxytocin antagonist atosiban Am. J. Perinatol. 13 1996 143 146
15. P. Husslein, L. Cabero Roura, J.W. Dudenhausen, H. Helmer, R. Frydman, N. Rizzo, and D. Schneider Atosiban versus usual care for the management of preterm labor J. Perinat. Med. 35 2007 305 313
16. M.M. Ijland, J.L. Evers, G.A. Dunselman, L. Volovics, and H.J. Hoogland Relation between endometrial wavelike activity and fecundability in spontaneous cycles Fertil. Steril. 67 1997 492 496
17. V. Knutzen, C.J. Stratton, G. Sher, P.I. McNamee, T.T. Huang, and C. Soto-Albors Mock embryo transfer in early luteal phase, the cycle before in vitro fertilization and embryo transfer: a descriptive study Fertil. Steril. 57 1992 156 162
18. N. Lédée-Bataille, G. Laprée-Delage, J.-L. Taupin, S. Dubanchet, R. Frydman, and G. Chaouat Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation Hum. Reprod. 17 2002 213 218
19. P. Lesny, S.R. Killick, R.L. Tetlow, J. Robinson, and S.D. Maguiness Embryo transfer-can we learn anything new from the observation of junctional zone contractions? Hum. Reprod. 13 1998 1540 1546
20. P. Lesny, S.R. Killick, J. Robinson, G. Raven, and S.D. Maguiness Junctional zone contractions and embryo transfer: is it safe to use a tenaculum? Hum. Reprod. 14 1999 2367 2370
21. P. Lesny, S.R. Killick, R.L. Tetlow, D.J. Manton, J. Robinson, and S.D. Maguiness Ultrasound evaluation of the uterine zonal anatomy during in-vitro fertilization and embryo transfer Hum. Reprod. 14 1999 1593 1598
22. Y.L. Liang, T.C. Kuo, K.H. Hung, T.H. Chen, and M.H. Wu Oxytocin antagonist for repeated implantation failure and delay of delivery Taiwan J. Obstet. Gynecol. 48 2009 314 316
23. E.A. Lyons, P.J. Taylor, X.H. Zheng, G. Ballard, C.S. Levi, and J.V. Kredenster Characterization of subendometrial myometrial contractions throughout the menstrual cycle in normal fertile women Fertil. Steril. 55 1991 771 774
24. R.T. Mansour, M.A. Aboulghar, and G.I. Serour Dummy embryo transfer, a technique that minimizes the problems of embryo transfers and improves the pregnancy rate in human in vitro fertilization Fertil. Steril. 54 1990 678 681
25. E.J. Margalioth, A. Ben-Chetrit, M. Gal, and T. Eldar-Geva Investigation and treatment of repeated implantation failure following IVF-ET Hum. Reprod. 21 2006 3036 3043
26. S. Mastenbroek, M. Twisk, F. van der Veen, and S. Repping Preimplantation genetic screening: a systematic review and meta-analysis of RCTs Hum. Reprod. Update 17 2011 454 466
27. H.S. Moon, S.H. Park, J.O. Lee, K.S. Kim, and B.S. Joo Treatment with piroxicam before embryo transfer increases the pregnancy rate after in vitro fertilization and embryo transfer Fertil. Steril. 82 2004 816 820
28. O. Moraloglu, E. Tonguc, T. Var, T. Zeyrek, and S. Batioglu Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after IVF Reprod. Biomed. Online 21 2010 338 343
29. J.M. Moutquin, D. Sherman, H. Cohen, P.T. Mohide, D. Hochner-Celnikier, M. Fejgin, R.M. Liston, J. Dansereau, M. Mazor, E. Shaley, M. Boucher, M. Glezemand, E.Z. Zimmer, and J. Rabinovici Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study Am. J. Obstet. Gynecol. 182 2000 1191 1199
30. R. Narayan, and R. Goswamy Subendometrial-myometrial contractility in conception and non-conception embryo transfer cycles Ultrasound Obstet. Gynecol. 4 1994 499 504
31. P. Pierzynski Oxytocin and vasopressin V(1A) receptors as new therapeutic targets in assisted reproduction Reprod. Biomed. Online 22 2011 9 16
32. P. Pierzynski, B. Gajda, Z. Smorag, A.D. Rasmussen, and W. Kuczynski Effect of atosiban on rabbit embryo development and human sperm motility Fertil. Steril. 87 2007 1147 1152
33. P. Pierzynski, T.M. Reinheimer, and W. Kuczynski Oxytocin antagonists may improve infertility treatment Fertil. Steril. 88 213 2007 e19 e213 e22
34. O.L. Pinheiro, M. Cavagna, R.L. Baruffi, A.L. Mauri, C. Petersen, and J.G. Franco Jr Administration of beta2-adrenergic agonists during the peri-implantation period does not improve implantation or pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles J. Assist. Reprod. Genet. 20 2003 513 516
35. H. Qublan, Z. Amarin, M. Dabbas, A.E. Farraj, Z. Beni-Merei, H. Al-Akash, A.N. Bdoor, M. Nawasreh, S. Malkawi, F. Diab, N. Al-Ahmad, M. Balawneh, and A. Abu-Salim Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial Hum. Fertil. 11 2008 246 253
36. R. Romero, B.M. Sibai, L. Sanchez-Ramos, G.J. Valenzuela, J.C. Veille, B. Tabor, K.G. Perry, M. Varner, T.M. Goodwin, R. Lane, J. Smith, G. Shangold, and G.W. Creasy An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue Am. J. Obstet. Gynecol. 182 2000 1173 1183
37. G. Sher, C. Zouves, M. Feinman, G. Maassarani, W. Matzner, P. Chong, and W. Ching A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies Am. J. Reprod. Immunol. 39 1998 391 394
38. M.D. Stephenson, and M.R. Fluker Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobin: a randomized, placebo-controlled Canadian trial Fertil. Steril. 74 2000 1108 1113
39. C. Stern, L. Chamley, Hale L. Norris, and H.W. Baker A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies Fertil. Steril. 80 2003 376 383
40. C. Tomas, J. Tapanainen, and H. Martikainen The difficulty of embryo transfer is an independent variable for predicting pregnancy in in-vitro fertilization treatments Fertil. Steril. 70 Suppl 1 1998 S433
41. M. Tsirigotis, M. Pelekanos, S. Gilhespie, S. Gregorakis, and G. Pistofidis Ritodrine use during the peri-implantation period reduces uterine contractility and improves implantation and pregnancy rates post-IVF Hum. Reprod. 15 2000 (Abstract book 1), p10
42. Twist M, Mastenbroek S, van Wely M, Heineman MJ, Van der Veen F, Repping S 2006 Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database Syst. Rev. Jan 25, 1: CD005291.
43. Y. Vedernikov, A. Betancourt, S. Shi, L. Shi, T. Reinheimer, and R. Garfield Oxytocin antagonistic effect of barusiban and atosiban in isolated uterine artery from late pregnant rats 2006 Annual Scientific Meeting of the Society for Gynecologic Investigation Toronto, Canada
44. L. Veeck An Atlas of Human Gametes and Conceptuses: An Illustrated Reference for Assisted Reproductive Technology 1999 Parthenon Publishers New York
45. H. Visnova, B. Coroleu, M. Piro, C. Blockeel, M. Mrázek, and J.C. Arce Barusiban and atosiban for reduction of uterine contractions on the day of embryo transfer do not alter the endocrine profile at the time of implantation Hum. Reprod. 24 Suppl. 1 2009 i178
46. D.S. Visser, F.L. Fourie, and H.F. Kruger Multiple attempts at embryo transfer: effect on pregnancy outcome in an in vitro fertilization and embryo transfer program J. Assist. Reprod. Genet. 10 1993 37 43
47. C. Wood, R. McMaster, G. Rennie, A. Trounson, and J. Leeton Factors influencing pregnancy rates following in vitro fertilization and embryo transfer Fertil. Steril. 43 1985 245 250
48. Worldwide Atosiban versus Beta-agonists Study Group Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour Br. J. Obstet. Gynaecol. 108 2001 133 142